Co Diagnostics Stock Investor Sentiment

CODX Stock  USD 1.01  0.05  4.72%   
Slightly above 61% of Co Diagnostics' investor base is looking to short. The analysis of overall sentiment of trading Co Diagnostics stock suggests that many investors are alarmed at this time. Co Diagnostics' investing sentiment can be driven by a variety of factors including economic data, Co Diagnostics' earnings reports, geopolitical events, and overall market trends.
  
over two months ago at www.macroaxis.com         
Acquisition by Brown Brian Lee of 225000 shares of Co Diagnostics subject to Rule 16b-3
Macroaxis News
over two months ago at news.google.com         
Disposition of 113334 shares by Brown Brian Lee of Co Diagnostics subject to Rule 16b-3
Google News at Macroaxis
over two months ago at news.google.com         
Co-Diagnostics sees shareholder backing in annual meeting votes - Investing.com
Google News at Macroaxis
over two months ago at zacks.com         
Are Medical Stocks Lagging Context Therapeutics Inc. This Year?
zacks News
over three months ago at simplywall.st         
Co-Diagnostics adds US8.6m to market cap in the past 7 days, though investors from three years ago a...
Simply Wall St News at Macroaxis
over three months ago at seekingalpha.com         
Mpox stocks are on the move as outbreak spreads globally
seekingalpha News
over three months ago at news.google.com         
Co-Diagnostics, Inc. to Present at 16th Next Generation Dx Summit in Washington, D.C. - Marketscreen...
Google News at Macroaxis
over three months ago at news.google.com         
Co-Diagnostics stock target cut by H.C. Wainwright - Investing.com
Google News at Macroaxis
over three months ago at insidermonkey.com         
Co-Diagnostics, Inc. Q2 2024 Earnings Call Transcript
insidermonkey News
over three months ago at investing.com         
Earnings call Co-Diagnostics Q2 earnings reflect growth and optimism
Investing News at Macroaxis
over three months ago at finance.yahoo.com         
Co-Diagnostics Second Quarter 2024 Earnings Beats Expectations
Yahoo News
over three months ago at investorplace.com         
CODX Stock Earnings Co-Diagnostics Beats EPS, Beats Revenue for Q2 2024
sbwire news
over three months ago at seekingalpha.com         
Co-Diagnostics GAAP EPS of -0.25 beats by 0.09, revenue of 2.66M beats by 2.28M
seekingalpha News
over three months ago at finance.yahoo.com         
Co-Diagnostics, Inc. Reports Second Quarter 2024 Financial Results
Yahoo News
over three months ago at seekingalpha.com         
Co-Diagnostics Q2 2024 Earnings Preview
seekingalpha News
Far too much social signal, news, headlines, and media speculation about Co Diagnostics that are available to investors today. That information is available publicly through CODX media outlets and privately through word of mouth or via CODX internal channels. However, regardless of the origin, that massive amount of CODX data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Co Diagnostics news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Co Diagnostics relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Co Diagnostics' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Co Diagnostics alpha.

Co Diagnostics Performance against Dow Jones

 Price Growth (%)  
       Timeline  

Additional Tools for CODX Stock Analysis

When running Co Diagnostics' price analysis, check to measure Co Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Co Diagnostics is operating at the current time. Most of Co Diagnostics' value examination focuses on studying past and present price action to predict the probability of Co Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Co Diagnostics' price. Additionally, you may evaluate how the addition of Co Diagnostics to your portfolios can decrease your overall portfolio volatility.